371 related articles for article (PubMed ID: 33417072)
21. GHB toxicokinetics and renal monocarboxylate transporter expression are influenced by the estrus cycle in rats.
Wei H; Cao J; Fallert T; Yeo S; Felmlee MA
BMC Pharmacol Toxicol; 2023 Nov; 24(1):58. PubMed ID: 37919807
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetic interaction between the flavonoid luteolin and gamma-hydroxybutyrate in rats: potential involvement of monocarboxylate transporters.
Wang X; Wang Q; Morris ME
AAPS J; 2008; 10(1):47-55. PubMed ID: 18446505
[TBL] [Abstract][Full Text] [Related]
23. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
24. Recreational use of GHB and prescribed drugs: the challenge in forensic and clinical toxicology.
Brunetti P; Umani Ronchi F
Clin Ter; 2021 Sep; 172(5):423-424. PubMed ID: 34625772
[TBL] [Abstract][Full Text] [Related]
25. Treatment of γ-Hydroxybutyrate (GHB) Overdose with the GABA
Follman KE; Morris ME
J Pharmacol Exp Ther; 2022 May; 382(1):21-30. PubMed ID: 35504663
[TBL] [Abstract][Full Text] [Related]
26. [Gamma-hydroxy butyric acid: neurotransmitter, sedative and party drug].
Meyer S; Kleinschmidt S; Gottschling S; Gortner L; Strittmatter M
Wien Med Wochenschr; 2005 Jul; 155(13-14):315-22. PubMed ID: 16092038
[TBL] [Abstract][Full Text] [Related]
27. Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid.
Morris ME; Felmlee MA
AAPS J; 2008 Jun; 10(2):311-21. PubMed ID: 18523892
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs.
Ricci G; Busardò FP; Gibelli F; Sirignano A; Brunetti P
Expert Opin Drug Metab Toxicol; 2021 Dec; 17(12):1445-1454. PubMed ID: 35043730
[TBL] [Abstract][Full Text] [Related]
29. Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
Amsterdam JV; Brunt TM; Pereira FR; Crunelle CL; Brink WVD
Curr Neuropharmacol; 2022; 20(4):809-819. PubMed ID: 34151766
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy.
Felmlee MA; Wang Q; Cui D; Roiko SA; Morris ME
AAPS J; 2010 Sep; 12(3):407-16. PubMed ID: 20461486
[TBL] [Abstract][Full Text] [Related]
31. GHB concentration in a related post-mortem case.
Mortali C; Berretta P
Clin Ter; 2020; 171(3):e235-e236. PubMed ID: 32323711
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.
Ferrara SD; Zotti S; Tedeschi L; Frison G; Castagna F; Gallimberti L; Gessa GL; Palatini P
Br J Clin Pharmacol; 1992 Sep; 34(3):231-5. PubMed ID: 1389947
[TBL] [Abstract][Full Text] [Related]
33. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
Caputo F; Vignoli T; Maremmani I; Bernardi M; Zoli G
Int J Environ Res Public Health; 2009 Jun; 6(6):1917-29. PubMed ID: 19578468
[TBL] [Abstract][Full Text] [Related]
34. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
35. The Xyrem risk management program.
Fuller DE; Hornfeldt CS; Kelloway JS; Stahl PJ; Anderson TF
Drug Saf; 2004; 27(5):293-306. PubMed ID: 15061684
[TBL] [Abstract][Full Text] [Related]
36. Interpreting γ-hydroxybutyrate concentrations for clinical and forensic purposes.
Busardò FP; Jones AW
Clin Toxicol (Phila); 2019 Mar; 57(3):149-163. PubMed ID: 30307336
[TBL] [Abstract][Full Text] [Related]
37. Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters.
Wang Q; Darling IM; Morris ME
J Pharmacol Exp Ther; 2006 Aug; 318(2):751-61. PubMed ID: 16707723
[TBL] [Abstract][Full Text] [Related]
38. [Gamma-hydroxybutyrate (GHB) and its lactone (GBL) as psychoactive substances].
Krajewska A; Kwiecień-Obara E; Szponar J; Majewska M; Kołodziej M
Przegl Lek; 2012; 69(8):544-7. PubMed ID: 23243924
[TBL] [Abstract][Full Text] [Related]
39. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.
Mamelak M; Scharf MB; Woods M
Sleep; 1986; 9(1 Pt 2):285-9. PubMed ID: 3704454
[TBL] [Abstract][Full Text] [Related]
40. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
